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Introduction: Coagulation assessment is often missing in microvascular surgery. We
aimed at evaluating the predictive value of thromboelastometry for free flap thrombosis
in microvascular surgery patients.
Materials and Methods: We enrolled 103 adult patients with traumatic injuries
scheduled for microvascular free flap surgery into a prospective observational study.
Thirty-six patients with recent trauma underwent surgery within 30 days (ES group), and
were compared with 67 trauma patients who underwent surgery later than 30 days (late
surgery, LS group) after the injury. Rotational thromboelastometry (RTE) was performed
before surgery. Functional fibrinogen to platelet ratio (FPR)≥ 42 was selected as the main
hypercoagulability index. Free flap thrombosis was set as primary outcome. Thrombotic
risk factors and duration of surgery related to free flap thrombosis were secondary
outcomes. Statistical significance p < 0.05; not significant NS.
Results: Six patients (16.7%) in the ES group and 10 (14.9%) in the LS group had
free flap thrombosis (NS). In the entire cohort, free flap thrombosis rate increased in the
presence of thrombogenic comorbidities (OR 4.059, CI 1.33–12.37; p = 0.014) and
prolonged surgery times (OR 1.007, CI 1 – 1.012; p= 0.05). Although hypercoagulability
occurred more frequently in the ES group (44.4%) than in the LS group (11.9%; p <
0.001), it was not associated with higher free flap thrombosis rate. In ES group patients
with surgery times > 240min, the risk of free flap thrombosis increased (OR 3.5, CI 1.16-
10.6; p = 0.026) with 93.3% sensitivity and 86.7% specificity (AUC 0.85; p = 0.007). In
contrast, in LS patients hypercoagulability increased the odds of free flap thrombosis (OR
8.83, CI 1.74–44.76; p = 0.009). Moreover, a positive correlation was found between
FPR ≥ 42 and free flap thrombosis rate (r = 0.362; p = 0.003). In the LS group, the
presence of thrombogenic comorbidities correlated with free flap thrombosis rate (OR 7,
CI 1.591–30.8; p = 0.01).
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Conclusions: In LS patients with thrombogenic comorbidities, thromboelastometry
supports the detection of hypercoagulability and predicts free flap thrombosis risk. In ES
patients, postoperative hypercoagulability did not predict free flap thrombosis. Prolonged
surgery time should be considered as a risk factor.
Keywords: free flap thrombosis, hypercoagulability, microsurgery, rotational thromboelastometry (RTEM), risk
INTRODUCTION
Microvascular free flap surgery allows closure of various tissue
defects in reconstructive microsurgery. Since the introduction of
free tissue transfer, advancements in microsurgical techniques
have increased flap survival rates (1–3). However, despite
technical progress, free flap thrombosis still remains a matter of
concern (4, 5) because it is associated with higher morbidity,
increased costs and, longer hospital stay. Ultimately, it might
lead to free flap failure (6). Although, microvascular free flap
thrombosis most often occurs secondary to technical mishaps
and/or longer duration of surgery (7), a number of other
preoperatively identifiable factors have a potential impact on
anastomotic thrombosis rate and outcome of tissue transfer (8–
10). Patient - related factors, such as hereditary or acquired
hypercoagulability (11–14), age (8), diabetes mellitus (15, 16),
poor nutritional status (17), cardiovascular diseases (6, 18) or
autoimmune disorders (11) were all demonstrated to affect
negatively the outcomes of tissue transfer surgery.
In trauma patients, a time-dependent hemostatic response
initially increases the risk of bleeding due to hemodilution
or consumption coagulopathy in combination with a rise in
fibrinolytic activity (19). Subsequently, a period of increased
pro-coagulant activity follows (20). Diagnosing a condition of
posttraumatic hypercoagulability is complex and no standardized
tests unequivocally give the answer. Thrombin generation
tests, or assessment of plasma levels of natural anticoagulants,
as protein C and S, are seldom available for clinical use
and not validated for detection of hypercoagulability. Routine
coagulation tests like activated partial thromboplastin time
(APTT) and prothrombin time (PT) are widely used to manage
anticoagulation therapy, but not for assessing the risk of excessive
bleeding or thrombosis. Several investigations have shown that
fibrinogen plasma levels of <1.5 g/L correlate highly with
increased risks of bleeding (21–23). In contrast, there is no
clear association between free flap thrombosis rate and higher
fibrinogen plasma levels. Besides that, a history of recent
traumatic injury in combination with posttraumatic coagulation
changes might increase microvascular thrombosis rate. Cho
and co-authors reported a 4-fold increased chance of lower
extremity free flap thrombosis and a doubling of the risks
of postoperative thrombosis in patients of acute trauma with
preoperative thrombocytosis (14).
In recent years, rotational thromboelastometry (RTE) has
become an extensively used method of monitoring coagulant
activity in major bleeding after trauma (24–26), cardiac surgery
(27, 28), and other conditions that might lead to great
blood losses (29). The method integrates real-time information
on all aspects of coagulation, including the presence of
hypercoagulability (30, 31). However, there are few reports on
the use of RTE for predicting the risks of free flap thrombotic
complications in patients undergoing microvascular surgery,
and the method is still controversial (32–34). We hypothesize
that hypercoagulability timely detected by RTE, can indicate
a higher risk of free flap thrombosis. Therefore, the aim of
this study was to assess the role of RTE as a means of early
identification of hypercoagulability in trauma patients prone to
develop free flap thrombosis. Hypercoagulability related to free
flap thrombosis until hospital discharge, was considered as a
primary outcome, and thrombotic risk factors and duration of
surgery were evaluated as secondary outcomes.
MATERIALS AND METHODS
Population
We enrolled 103 subsequent adult patients with traumatic
injuries scheduled to undergo microvascular free flap surgery at
the Latvian Center of Reconstructive and Microsurgery, Riga,
Latvia into a prospective observational study. We compared two
groups of patients according to the time that had elapsed from the
traumatic event until the day of surgery. Thirty-six patients, who
were operated within a 30-day period after trauma, during the
primary hospital stay, were allocated to an early surgery group
(ES group), and the remaining 67 patients were referred to a
late surgery group (LS group) that was operated later than 30
days after the injurious trauma due to late complications, such
as infections or scars. In those cases, tissue defects were closed
secondary in the late posttraumatic period.
The Ethics Committee of Riga Stradinš University approved
the study protocol (Nr.1/26-11-16) and the informed consent
form. All adult patients with traumatic injuries who underwent
microvascular free flap surgery during the study period were
asked to participate in the study. We excluded patients below
18 years of age and patients with ongoing oncological treatment
or history of confirmed thrombophilia or pregnancy. Surgery
was performed as a consequence of acute or chronic traumatic
injuries. All patients gave their prior written informed consent.
Perioperative Management
General anesthesia (GA) was provided for all enrolled patients
according to the guidelines for free flap transfer surgery. After
induction with fentanyl (Fentanyl-Kalceks R© 0.05 mg/ml, A/S
Kalceks, Latvia) 1.5–2 µg/kg, and propofol (Propofol R© 10
mg/ml, Fresenius Kabi AG, Germany) 1–2 mg/kg intravenously
(iv), GA was maintained with sevoflurane (Sevorane R©, AbbVie
S.r.l., Italy) 0.8–1.2 MAC, and fentanyl 1–1.5 µg/kg/h. We
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administered cisatracurium (Nimbex 2 mg/ml, Aspen Pharma
Ltd, Ireland) 0.15 mg/kg iv for tracheal intubation, followed by
a continuous infusion of 1–2 µg/kg/min for muscle relaxation.
Crystalloid infusion (RiLac, B. Braun Melsungen AG, Germany)
of 3.5 to 6.0 ml/kg iv per hour during the 24-h perioperative
period was standardized and controlled for adequacy guided
by monitoring of a urine output of 1–2 ml/kg/h. To avoid
hypothermia, we measured central (esophageal probe) and
peripheral (axillary probe) temperatures (◦C) of the patients,
maintaining core temperatures above 35◦C and a difference
between central and peripheral measurements (1t) of <2◦C.
We assessed patients’ volume status by evaluating urine output
and 1t combined, in addition to hemodynamic parameters. The
decision to insert a line for central venous pressure monitoring
was guided by the patient’s cardiovascular status, anticipated
blood loss and need of vasoactive substances.
We performed peripheral blocks under ultrasound guidance
when indicated. We applied brachial plexus block with axillary
approach for upper extremity surgery, femoral nerve and
popliteal blocks for lower extremity postoperative analgesia.
Paracetamol (Paracetamol, B. Braun Melsungen AG, Germany)
1.0 g four times daily in combination with non-steroidal anti-
inflammatory drugs two times daily were used for postoperative
multimodal analgesia. For those without a peripheral nerve
block, we administered a continuous intravenous infusion of
fentanyl 0.5–1 mcg/kg/h.
Postoperatively, tightly followed hemodynamic monitoring,
fluid management and oxygen supply was provided in the
post-anesthesia care unit. According to hospital guidelines,
postoperative thrombotic prophylaxis was provided with
enoxaparin 40mg (CLEXANE R©, Sanofi-Aventis S.A. Spain)
once daily from the 1st postoperative day for all included
patients. Hemoglobin and hematocrit levels were optimized
(Hb > 10 g/dl, Hct > 30%) in anemic patients with allogenic
hemotransfusions before surgery. During and after surgery,
patients with clinical symptoms of excessive blood loss or those
with Hb <7 g/dl received blood product transfusions.
During the study, the same team of specialists trained
in microsurgery performed all microvascular flap surgeries.
The surgeon monitored the microvascular flap for 3–5
days postoperatively. Clinical assessment of flap color and
temperature, tissue turgor and capillary refill were evaluated as
flap perfusion criteria. In all cases of free flap thrombosis, urgent
surgical re-exploration was performed in order to salvage the
transferred free flap. The venue of thrombosis (e.g., arterial,
venous or both) was assured by direct visualization during
revision of the anastomosis.
Study Protocol
Preoperatively, a blood sample was drawn for RTE (ROTEM R©,
Tem Innovations GmbH, Munich, Germany) assessment of
the coagulation status. For each RTE test, we used 300 µl of
citrated blood with 20 µl of 0.2 mol/L CaCl2 for recalcification.
As activators, we added 20 µl of recombinant tissue factor
for EXTEM test, 20 µl of partial thromboplastin phospholipid
from rabbit brain for INTEM test, and 20 µl cytochalasin D
for FIBTEM test. For all three test assays, we recorded the
following parameters of RTE: clotting time (CT, period from
start of clot formation to the first visible clotting; normal range
for EXTEM 38–79 s, normal range for INTEM 100–240 s); clot
formation time [CFT, time to the clot reached a diameter of 20
millimeters (mm); normal range for EXTEM 34–159 s, normal
range for INTEM 30–110 s], MCF-maximum clot firmness (the
maximum clot diameter in mm; normal ranges for EXTEM
and INTEM 50–72mm, normal range for FIBTEM 9–25mm)
(35). Hypercoagulability was defined as functional fibrinogen to
platelet ratio (FPR) higher or equal to 42, as previously described
by Parker et al. (32). To calculate FPR maximum, we divided clot
firmness of FIBTEM (MCFFIBTEM) by MCFINTEM, as expressed
by a numerical ratio.
In parallel, we performed standard coagulation
measurements. Prothrombin index (PI, normal range 70–
130%), activated partial thromboplastin time (APTT, normal
range 28–40 s) and fibrinogen plasma levels (normal range
2–4 g/L) were analyzed in citrated plasma using the STA-R
COMPACT (Diagnostika Stago, France). Platelet count (normal
range 150–400 × 109/L) was determined by using Sysmex
XE-5000 (Sysmex Kobe, Japan).
In search of thrombogenic risk factors, the patients were
interviewed in order to register co-morbidities, particularly
emphasizing histories of previous thrombotic events. In parallel,
we noted demographic data, localization of soft tissue defect and
the duration of surgery. We defined trauma as recent if the free
flap had been transferred within 30-days after the injury.
Statistical Analysis
Data were analyzed with SPSS Statistics (Chicago, IL, Version
20). We assessed the data distribution with Shapiro-Wilk test
because the sample size was small. Continuous variables were
presented as mean ± standard deviation (SD) or median
with interquartile range (IQR), as appropriate, and categorical
variables as percentages (%). Quantitative (continuous) data were
non-normally distributed (except for age of patients). Therefore,
we used non-parametric Kruskal-Wallis H test to compare
differences between quantitative data. Cross tabulation was used
to compare free flap thrombosis (yes/no), time to operation (ES,
LS) and demographics, clinical data and RTE variables. To assess
statistical differences between the abovementioned data, we used
Pearson Chi Square test and if small sample size (<5 cases)
Fisher’s exact test. Correlations between free flap thrombosis
factors were performed with non-parametric Spearman rho test.
ROC curve analysis was performed to state the diagnostic value
of FPR for free flap thrombosis with threshold level of ≥ 42.
We employed ROC curve analysis to find the thresholds for
sensitivity and specificity of FPR, and duration of surgery and
furthermore, to find the threshold of operation time at which
the risk of thrombosis is high. Linear regression was performed
to find adjusted predicted values of thrombosis for the length
of operation. We also performed binary regression analysis in
the entire population and in subgroups of early (ES group)
and late surgery (LS group) patients to find significant free flap
thrombosis factors. Statistical significance was reached at alpha
level < 0.05.
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TABLE 1 | Comparison of demographic data, thrombogenic risk factors, trauma
localization, and duration of surgery between patients of the early surgery (ES)
group and the late surgery (LS group).










Gender, female, n (%) 4 (11.1) 9 (13.4) NS
Thrombogenic risk factors, n (%)
Thrombogenic
comorbidities*
4 (11.1) 21 (31.8) 0.029
Chronic osteomyelitis 0 22 (32.8) < 0.001
Smoking 16 (44.4) 23 (34.3) NS
Thrombocytosis 10 (27.8) 11 (16.4) NS
Hyperfibrinogenemia,
> 4 g/L
23 (63.9) 23 (34.3) < 0.001
Trauma localization, n (%)
Lower extremity 30 (83.3) 40 (59.7) 0.014
Upper extremity 6 (16.7) 21 (31.3) NS
Lumbar region 0 2 (3) NS








Data are presented as mean ± SD or number (n) or median and interquartile range (IQR).
n, number of patients; %, per cent; NS, non-significant difference; SD, standard deviation.
*Thrombotic comorbidities: history of previous thrombosis, ischemic disease,
hypertension, obesity, neuroparesis, diabetes.
RESULTS
Clinical Course
Table 1 displays demographic and clinical variables of 90
men and 13 women fulfilling the inclusion criteria and all
requirements of the protocol, including thrombogenic risk
factors, localization of tissue defects and durations of surgery.
Demographic data did not differ significantly (NS) between
the groups (Table 1). As expected, thrombogenic risk factors
like chronic osteomyelitis (p < 0.001) and thrombogenic
comorbidities (p = 0.029) appeared significantly more often in
the LS group, whereas posttraumatic hyperfibrinogenemia with
fibrinogen plasma levels > 4 g/L were registered more frequently
in the ES group (p< 0.001). There were no significant differences
in smoking history, thrombocytosis or surgery time between the
groups. Interestingly, the ES group patients underwent mainly
lower extremity reconstruction (83.3%). The most frequent
locations of myocutaneus free flap surgeries were on the
scapula and in the parascapular area (21.3%), as well as in the
anterolateral area of the thigh (12.6%) and the latissimus dorsi
muscle area (13.5%). Fibula transposition was the most frequent
bone tissue type (9.7%).
Preoperative Coagulation, Blood Variables,
and RTE Parameters
As shown in Table 2, we observed no differences between the
two groups in preoperative APTT, PI and platelet count. In
contrast, when comparing ES and LS group patients, the former
TABLE 2 | Comparison of hematological variables, conventional coagulation
tests, and rotational thromboelastometry (RTE) variables between early surgery






Hematological variables, mean ± SD
Hb, g/dL 11.1 ± 1.6 13.6 ± 2.4 < 0.001
PLT, 109/L 358 (435–208) 281 (337–239) NS
Conventional tests, mean, (max-min)
Fibrinogen, g/L 4.41 (5.45–3.7) 3.74 (4.62–2.95) 0.003
APTT, sec 33 (35–29.9) 32.9 (35.3–29.4) NS
PI, % 96 (106–75) 101 (111–87) NS
RTE parameters, mean (max-min)
CT EXTEM 59.5 (68–54) 62 (72–56) NS
CFT EXTEM 48.5 (68–40) 71 (87–52) 0.001
MCF EXTEM 73.5 (77–68) 66 (72–63) 0.001
CT INTEM 164 (193–137) 185 (233–149) 0.013
CFTINTEM 47.5 (61–40) 69 (89–54) < 0.001
MCF INTEM 70 (75–66) 65 (69–61) 0.001
CT FIBTEM 55.5 (65–48) 57 (64–52) NS
CFTFIBTEM 76 (160–52) 139 (503–36) 0.002
MCF FIBTEM 26.5 (34–21) 19 (25–15) < 0.001
Data are presented as mean ± SD or mean (max–min). APTT, activated partial
thromboplastin time; sec, seconds; CT, clotting time; CFT, clot formation time; Hb,
hemoglobin concentration; MCF maximum clot firmness; PLT, platelet count; PI,
prothrombin index; NS, non-significant difference.
presented significantly more often with a lower Hb level (p <
0.001), and higher fibrinogen plasma concentration (p = 0.001),
that is characteristic for the acute posttraumatic period.
Assessing preoperative RTE parameters, significant
shortening of clot formation time (CFT) and increase in
maximum clot firmness (MCF) were detected in the ES group.
In contrast, we found no differences between the groups with
regard to plasma coagulation, as evidenced by clotting time
(except CT INTEM, p= 0.013).
Association of Hypercoagulability and Free
Flap Thrombosis
Free flap thrombosis developed within the first 24 h after surgery
in 16 patients (15.5 %) without significant intergroup difference
(Table 3).
Hypercoagulability detected by RTE was seen in totally 24
patients, and more often in the ES group (p < 0.001), as
demonstrated in Table 3. Hypercoagulability presented as a
significant risk factor for free flap thrombosis (OR 8.83, CI 1.74–
44.76; p= 0.009) in the LS group patients, as depicted in Table 4.
Additionally, in the same group we found positive correlations
between free flap thrombosis rate and FPR ≥ 42 (r = 0.362; p =
0.003), MCF EXTEM (r = 0.257; p= 0.036), and MCF FIBTEM (r =
0.257; p= 0.036).
Although 44.4% of the patients in the ES group had
hypercoagulability (FPR ≥ 42), it did not affect the rate of free
flap thrombosis.
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Free flap thrombosis, n (%) 16 (15.5%) 6 (16.7%) 10 (14.9%) NS
Hypercoagulability, FPR ≥
42, n (%)
24 (23%) 16 (44.4) 8 (11.9) < 0.001
Data are presented as categorical variable with number (n) and percentage (%); NS, non-significant difference.
TABLE 4 | Thrombogenic risk factors and duration of surgery in association with free flap thrombosis in early surgery (ES group) and late surgery (LS group) patients.
ES group, n = 36 LS group, n = 67
Variables Odds ratio Confidence interval (95%) p value Odds ratio Confidence interval (95%) p value
Thrombogenic risk factors
Smoking 1.308 (0.226–7.568) NS 0.793 (0.185–3.406) NS
Age 0.94 (0.867–1.019) NS 1.014 (0.958–1.073) NS
Thrombogenic comorbidities* 1.8 (0.154–20.98) NS 7 (1.591–30.8) 0.010
Hypercoagulability (FPR >42) 0.571 (0.091–3.608) NS 8.83 (1.743–44.76) 0.009
Duration of surgery
Duration of surgery, min 1.007 (1.000–1.012) 0.05 1.007 (1.000–1.012) 0.05
*Thrombogenic comorbidities: history of previous thrombosis, ischemic disease, hypertension, obesity, neuroparesis, diabetes.
Association of Thrombogenic Risk Factors
and Duration of Surgery in Free Flap
Thrombosis
By assessing the possible influence of thrombogenic risk factors
and duration of surgery on free flap thrombosis rate in all
the enrolled patients, we found that those with previous
thrombogenic comorbidities had a 4-fold increased odds of free
flap thrombosis (OR= 4.059; p= 0.014). The latter patients were
more often presented in LS group. Additionally, multifactorial
analysis showed that combination of hypercoagulability in RTE
and time to surgery increases risk for free flap thrombosis (OR=
1.01; p= 0.016) in the whole population.
Late Surgery Group
In addition to hypercoagulability (FPR ≥ 42), as a marked
risk factor for free flap thrombosis, a history of thrombogenic
co-morbidities demonstrated an influence on flap thrombosis
rate (OR 7, CI 1.591–30.8); p = 0.01. A positive correlation
was detected between hypercoagulability and the presence of
thrombogenic comorbidities r= 0.277; p= 0.024.
Early Surgery Group
Duration of surgery appears to be a main predisposing factor
for free flap thrombosis in the ES group. Prolonged duration
of surgery demonstrated a tendency to promote development of
postoperative thrombosis (OR = 1.007; p = 0.05), as depicted in
Table 4. Moreover, we found that the risk of free flap thrombosis
increased gradually with the duration of surgery as shown in
Figure 1. Duration of surgery> 240min increased the risk of free
flap thrombosis 3.5 times, as determined with binary regression
analysis (OR 3.5, CI 1.16–10.6; p = 0.026). In addition, linear
regression analysis showed that surgery time from 240 up to
300min increased the risk of free flap thrombosis by 34%.
According to ROC analysis (Figure 2), duration of surgery
exceeding 240min in ES group patients revealed a diagnosis of
free flap thrombosis with a sensitivity of 93.3% and specificity of
86.7% and an AUC of 0.85; p= 0.007.
DISCUSSION
In microvascular surgery, a score, which identifies patients
at increased risk of free flap thrombosis, is still lacking.
The present prospective study of 103 patients with traumatic
injuries, who underwent microvascular surgery, demonstrates
that assessment of RTE data can be a useful tool for detection
of hypercoagulability, although its prognostic value varies
depending on the elapsed time after trauma. RTE might be
convenient for predicting free flap thrombosis, particularly
in patients who undergo elective surgery later than 30-days
after a traumatic injury. The presence of hypercoagulability,
which is often associated with thrombogenic comorbidities,
increases the risk of free flap thrombosis as well. Although
most patients in the ES group presented with posttraumatic
hypercoagulability, the duration of surgery appeared to play
an important role, independent of age, sex and localization of
trauma and tissue defect.
Most investigators agree that traumatic injury promotes
hypercoagulability. This occurs within only a few hours
of the injurious event and leads to an elevated risk of
thromboembolic complications. Muller et al. (31), analyzed RTE
data from 886 trauma patients and observed that 10 % had
hypercoagulability already during the first 24 h upon admission.
Correspondingly, Selby and co-workers (35), examining 135
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FIGURE 1 | Relationship between risk of free flap thrombosis and duration of surgery in early surgery patients (ES group). In the ES group, the following subgroups
were included as based on the duration of surgery (min, minutes), 19 patients < 180min, 48 patients from 181 to 249min, 18 patients from 241 to 300min and 18
patients > 300min. Demographics, like age and sex did not differ significantly between the subgroups except for lower extremity surgery, which was performed less
often in the subgroup with surgery time exceeding 300min, respectively, p = 0.021. * denotes intergroup p = 0.024 between duration of surgery less and more than
300min.
victims of major traumas, demonstrated an overall incidence
of venous thromboembolism (VTE), including asymptomatic
deep vein thrombosis in 59% of the patients. The authors also
validated various coagulation and fibrinolysis markers for a
potential role as predictors of VTE, but without pointing out any
factor with such capability. Increased age was the only significant
independent predictor of VTE.
During the recent few years, several studies have validated
the ability of viscoelastic assays like RTE for monitoring of
patients at increased risk of thrombophilia and thrombotic events
(36–38). Thus, we chose RTE as the main diagnostic tool for
assessing patients that potentially could be prone to free flap
thrombosis. Of all the functionalities offered by this technology,
the fibrinogen to platelet ratio (FPR) of RTE was considered to be
the main index of hypercoagulability (32).
In the present study, free flap thrombosis developed in 15.5%
of the patients regardless of time period after the traumatic
event. Despite reports of progressive hypercoagulability and
posttraumatic thrombotic complications followingmajor surgery
(39, 40), we miss data of hypercoagulability after trauma, that
can predict the course of microvascular free flap thrombosis.
We believe that coagulation activity escalates during the
posttraumatic period. Based on our findings with RTE, 23% of
all patients demonstrated hypercoagulability. Although incidence
of FPR ≥ 42 in the ES group was significantly higher
(44.4%) as compared with the LS group (11.9%), it did not
correlate with the incidence of free flap thrombosis. Moreover,
we showed that in patients with RTE data consistent with
hypercoagulability, the incidence of free flap thrombosis was
25 vs. 12.7% in those without hypercoagulability, albeit the
difference did not reach significance. A similar trend was also
reported by Kolbenschlag and co-authors, who demonstrated
RTE-based hypercoagulability in 36.5% of the patients who
underwent microvascular surgery and an incidence of free
flap thrombosis reaching 15.5% (34). The authors concluded
that hypercoagulability detected by RTE at a FPR ratio >
43 identified patients likely to have thrombotic free flap
complications. This corresponds to our findings. However,
when hypercoagulability was associated with thrombogenic
co-morbidities, free flap thrombosis rate was higher. In
comparison with the study of Kolbenschlag et al., our ES
patients were younger and had less thrombogenic co-morbidities.
Therefore, we assume that hypercoagulability in association with
thrombogenic comorbidities plays a more important role as
compared with posttraumatic hypercoagulability.
According to Parker et al., FPR ≥ 42 might be a useful
index for identifying patients at increased risk of contracting
postoperative thrombosis after microvascular surgery (32). These
authors included only patients with known head and neck tissue
defects after oncological treatment. Moreover, they compared
data from surgical patients with those of healthy volunteers
assessing all thromboembolic complications. They demonstrated
a predictive value of hypercoagulability, as assessed by RTE (with
FRP ≥ 42) with a sensitivity of 89% and a specificity of 75% for
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FIGURE 2 | ROC curve showing sensitivity and specificity of duration of
surgery for predicting free flap thrombosis risk in early surgery patients (ES
group). Sensitivity and specificity were 93.3 and 86.7%, respectively (AUC
0.85; p = 0.007), for duration of surgery with a cut off value of 240min of
increased risk of free flap thrombosis in ES group patients.
thrombotic events. They found that nine (31%) of the patients
had undergone some thromboembolic event and 8 of them had
hypercoagulability with FPR ≥ 42. The authors noticed that
patients with malignant diseases were at increased risk of venous
thromboembolism per se.
In our cohort of 103 patients the main factors, revealing
significant correlations with higher postoperative flap thrombosis
rate, was the presence of thrombotic comorbidities in the
LS group and the duration of surgery in the ES group.
Previous investigators have demonstrated that smoking history
(41), chronic obstructive pulmonary disease (42), diabetic
complications (15), chronic cardiac failure (18) and peripheral
vascular disease (6), all promote flap failure. We registered the
history of previous thrombosis of any origin, such as ischemic
disease, hypertension, obesity, neuroparesis, and diabetes as
predisposing factors. It should be noted that LS group patients
had significantly more frequent thrombotic comorbidities as
compared with patients in the ES group. A possible explanation
could be that younger people are more active and prone to
traumas, whereas postponed reconstruction might occur more
frequently in older ages, when health problems of various kinds
have become manifest. We also observed, that LS patients were
slightly older, 42.4 vs. 37.6 years. Regarding chronic osteomyelitis
as a late posttraumatic complication, it was registered exclusively
in 22 out of 67 patients (32.8%) of the LS group. We did
not find any correlation between osteomyelitis and free flap
thrombosis rate.
Whereas, most published studies have focused on thrombotic
complications in oncological reconstruction surgery (6, 41, 43,
44) or a mixed population (42), few papers only have analyzed
trauma cases (45). Moreover, only a few studies have assessed
free flap thrombosis risk and the time elapsed between the
traumatic event and microvascular reconstruction (14). To date,
no one study has considered a possible influence of RTE-based
hypercoagulability on flap thrombosis risk by comparing patients
operated in an “early” posttraumatic period of up to 30-days after
injury and a postponed reconstruction on an elective basis (later
than 30 days).
Notably, Wikner and co-authors argued that RTE could be
recommended only for assessment of anticoagulation therapy
in free flap surgery patients (33). In our study, the surgeons
ordinated enoxaparin 40mg postoperatively as a standard
thrombosis prophylaxis without individual risk assessment. Data
regarding anticoagulation regimens still remain inconclusive.
Clinical studies comparing various regimens have shown
a reduction in the incidence of thrombotic complications,
including anastomotic thrombosis and flap loss (43, 46). In
general, anticoagulation therapy is administered, mostly because
of difficulties in specifically detecting patients at increased
thrombotic risks (34).
There are some limitations of our study. Although, all
patients received standardized treatment, and were operated by
experienced plastic surgeons routinely performing microvascular
surgery, we consider technical surgical factors as the most
actual limitations. Anyhow, we were not able to avoid the
multifactorial nature of a thrombotic event and the human
factor in surgery and postoperative care. In microvascular flap
thrombosis, both the arterial and venous pools may play a
role, which is further augmented by the genetic background
of the patients (47, 48) or acquired thrombophilia. Therefore,
we warrant an appropriate thrombotic risk assessment score
for microvascular surgery patients. The CHAD2S2-VASc and
the Caprini scores have been used to evaluate the risks of
stroke in patients with atrial fibrillation and the risks of
overall thromboembolic events in various patient populations.
Nevertheless, we have no access to a method confidently
estimating the risks of microvascular flap thrombosis (49–
51). Moreover, we have not calculated the overall thrombosis
risks preoperatively, which we denote as a weakness of the
study. In addition, we did not address the possible influence
of thrombosis promoting factors with regard to the type and
severity of the primary injury in this patient population.
Several investigators have analyzed the outcomes of free flap
transfer surgery in certain body areas, such as head, neck and
breast (52–55). Recently, Cho et al. demonstrated a positive
predictive value of preoperative thrombocytosis for free flap
thrombosis in acute trauma patients, but only in lower extremity
reconstruction surgery (14). Finally, low incidence of RTE-
detected hypercoagulability and free flap thrombosis rate in the
LS group, and non-normally distributed data, revealed a rather
wide confidence interval.
We were not able to show significant sensitivity and
specificity of RTE - detected hypercoagulability and risk of
free flap thrombosis in ES patients, although the patients
often presented with posttraumatic hypercoagulability.
Sample size was undersized as the statistical power
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was 69%, as tested with general linear model repeated
measures test. However, assuming an incidence of free flap
thrombosis of 15.5% in the whole population, and 33.3%
in ES patients with RTE hypercoagulability, would reach
a significance level of ≤ 0.05 at a power of 80% for the
development of free flap thrombosis by increasing sample
size in the ES group to 39 patients with hypercoagulability.
So, admittedly the present study was not powered for
this estimation.
CONCLUSIONS
Thromboelastometry supports the detection of
hypercoagulability and might have a predictive value for
detection of free flap thrombosis in LS patients with thrombotic
comorbidities. Although more patients were presented with
posttraumatic hypercoagulability in the ES group, it is not
predictive for free flap thrombosis. Prolonged surgery time
(>240min) should be considered as a major risk factor in
these patients.
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